<qa>  What is the term for progression on or within 60 days of treatment with these agents?Diagnosis of MM with relapsed or refractory disease and have had at least 3 different prior lines of therapy including proteasome inhibitor e.g., bortezomib or carfilzomib and immunomodulatory therapy IMiD; e.g., lenalidomide or pomalidomide, or have double refractory disease to a proteasome inhibitor and IMiD, defined as progression on or within 60 days of treatment with these agents 